Literature DB >> 24656943

Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.

Jennifer L Whitwell1, Christopher G Schwarz2, Robert I Reid2, Kejal Kantarci2, Clifford R Jack2, Keith A Josephs3.   

Abstract

BACKGROUND: Corticobasal syndrome (CBS) and progressive supranuclear palsy syndrome (PSPS) are atypical parkinsonian syndromes that are both associated with white matter tract degeneration. However, little is known about how patterns of degeneration compare across these two syndromes.
METHODS: Twenty-seven subjects, nine with CBS and eighteen with probable or definite PSPS (9 pathologically confirmed) were prospectively recruited and underwent 3.0 T diffusion tensor imaging. A whole-brain voxel-based analysis was performed on fractional anisotropy (FA) and mean diffusivity (MD) images to compare both groups to each other and to 50 healthy controls.
RESULTS: The two syndromes showed overlapping regions of reduced FA and increased MD in the body of the corpus callosum, middle cingulum bundle, and premotor and prefrontal white matter, with reduced FA also observed in the superior cerebellar peduncles in both syndromes. However, CBS showed a more supratentorial and posterior pattern of degeneration with greater involvement of the splenium of the corpus callosum, premotor, motor and parietal lobes than PSPS. Findings in CBS were also highly asymmetric. Conversely, PSPS showed a more symmetric and infratentorial pattern of degeneration, with greater involvement of the superior cerebellar peduncles and midbrain than CBS.
CONCLUSIONS: CBS and PSPS are both associated with striking white matter tract degeneration. Despite differences in the supratentorial and infratentorial distribution of degeneration, and in asymmetry, both tend to target a common structural network. Measurements of white matter tract diffusion could therefore be useful disease biomarkers in both of these syndromes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diffusion tensor imaging; Parkinsonism; Premotor; Structural network; Superior cerebellar peduncle; White matter

Mesh:

Substances:

Year:  2014        PMID: 24656943     DOI: 10.1016/j.parkreldis.2014.01.023

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  17 in total

Review 1.  Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.

Authors:  Keita Sakurai; Aya M Tokumaru; Keigo Shimoji; Shigeo Murayama; Kazutomi Kanemaru; Satoru Morimoto; Ikuko Aiba; Motoo Nakagawa; Yoshiyuki Ozawa; Masashi Shimohira; Noriyuki Matsukawa; Yoshio Hashizume; Yuta Shibamoto
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

2.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Neeraj Upadhyay; Antonio Suppa; Maria Cristina Piattella; Matteo Bologna; Flavio Di Stasio; Alessandra Formica; Francesca Tona; Carlo Colosimo; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2016-07-13       Impact factor: 4.849

3.  Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.

Authors:  Katerina A Tetzloff; Joseph R Duffy; Heather M Clark; Edythe A Strand; Mary M Machulda; Christopher G Schwarz; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Nirubol Tosakulwong; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

Review 4.  Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.

Authors:  Keith A Josephs
Journal:  J Neurol       Date:  2015-02-21       Impact factor: 4.849

5.  Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Robert Reid; Matthew C Baker; Ralph B Perkerson; Val J Lowe; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain Lang       Date:  2015-02-03       Impact factor: 2.381

6.  Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.

Authors:  Ji-Hyun Choi; Heejung Kim; Jung Hwan Shin; Jee-Young Lee; Han-Joon Kim; Jong-Min Kim; Beomseok Jeon
Journal:  J Neurol       Date:  2020-09-21       Impact factor: 4.849

7.  Dentatorubrothalamic tract reduction using fixel-based analysis in corticobasal syndrome.

Authors:  Shun Sakamoto; Takashi Kimura; Koji Kajiyama; Kumiko Ando; Masanaka Takeda; Hiroo Yoshikawa
Journal:  Neuroradiology       Date:  2020-09-29       Impact factor: 2.804

Review 8.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

Review 9.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

10.  Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.

Authors:  Yu Zhang; Rudolph Walter; Peter Ng; Phi N Luong; Shubir Dutt; Hilary Heuer; Julio C Rojas-Rodriguez; Richard Tsai; Irene Litvan; Bradford C Dickerson; Maria Carmela Tartaglia; Gil Rabinovici; Bruce L Miller; Howard J Rosen; Norbert Schuff; Adam L Boxer
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.